TECH BUYER Jul 2020 - Tech Buyer Presentation - Doc # AP46693020
Artificial Intelligence in India Healthcare in the Time of COVID-19
This IDC Tech Buyer presentation highlights how COVID-19 has been an accelerating agent in the adoption of artificial intelligence (AI) in the India healthcare sector and discusses the changing state of AI adoption in the country post–COVID-19. The report zooms in on certain potential AI start-ups in India by underlining their innovative solutions as well as examining the barriers for healthcare organizations in adopting AI solutions. AI-specific case studies from leading organizations, along with respective technology providers, will inspire many care providers. The section on new standards for AI in healthcare can act as a trigger for decision makers to think beyond technology while opting for AI solutions. The report concludes with a set of guidance for technology buyers while prioritizing AI adoption.
"Healthcare organizations in India are on their path to accelerate the adoption of AI solutions, taking drive from the COVID-19 pandemic. Moving forward, healthcare providers in India are set to reprioritize the adoption of electronic medical records (EMRs). While deploying AI solutions, CIOs will have to look beyond technology by ensuring strict adherence to regulatory compliance, along with data governance and ethics, to ensure public trust and scalability," says Manoj Vallikkat, research manager, IDC Asia/Pacific Healthcare Insights.
Fortis Healthcare Limited, Invento Robotics, Apollo Hospitals Enterprise Limited, Tricog Healthcare Services Private Limited, Turtle Shell Technologies Private Limited, Qure.ai Technologies Private Limited, Indian Council of Medical Research, Docturnal, ZEBRA MEDICAL VISION LTD, IBM, Niramai Health Analytix Private Limited, NOVOCURA TECH HEALTH SERVICES PRIVATE LIMITED, Behold.ai Technologies Limited